Yale researchers weigh in on new COVID-19 drug

Pemgarda, a monoclonal antibody infusion recently authorized by the FDA, could offer a new line of protection for millions of immunocompromised patients.

Related Keywords

Cuba ,Carlos Salcerio ,Albert Ko ,Akiko Iwasaki ,Drug Administration ,Biochemistry In Jonathan Edwards College ,Yale School Of Nursing For The Scitech ,School Of Public Health ,School Of Medicine ,Yale School Of Medicine ,Shiv Gandhi ,Public Health ,Yale School ,Molecular Biophysics ,Jonathan Edwards ,